Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.

BACKGROUND: Umbilical cord blood provides a source of hematopoietic stem cells for transplantation with immunological and availability advantages over conventional bone marrow sources. Limited cell numbers and slower engraftment from umbilical cord blood units has led to the clinical development of...

Full description

Saved in:
Bibliographic Details
Main Authors: Rebecca Moore, Matthew J. Worrallo, Peter D. Mitchell, Jon Harriman, Katie Glen, Rob Thomas
Format: Default Article
Published: 2017
Subjects:
Online Access:https://hdl.handle.net/2134/26082
Tags: Add Tag
No Tags, Be the first to tag this record!
id rr-article-9564008
record_format Figshare
spelling rr-article-95640082017-08-04T00:00:00Z Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor. Rebecca Moore (1253241) Matthew J. Worrallo (7201355) Peter D. Mitchell (7129847) Jon Harriman (4334050) Katie Glen (1255023) Rob Thomas (1249266) Mechanical engineering not elsewhere classified Cell culture Delta-like 1 Ex vivo expansion Hematopoietic progenitor cell Immobilised Manufacturing Notch Scalable Mechanical Engineering not elsewhere classified BACKGROUND: Umbilical cord blood provides a source of hematopoietic stem cells for transplantation with immunological and availability advantages over conventional bone marrow sources. Limited cell numbers and slower engraftment from umbilical cord blood units has led to the clinical development of immobilised Notch ligand Delta-Like 1 to promote ex vivo expansion of a rapidly engrafting cell population. However, current immobilisation methods are not simple to scale in a controlled manner. RESULTS: Delta-Like 1 was immobilised onto streptavidin coated magnetic particles via a heterobifunctionalised polyethylene glycol linker molecule to provide an easily manipulated format of surface protein presentation. CD34(+) enriched cord blood cells were treated with Delta-Like 1 immobilised particles, and immunophenotypic markers measured to monitor population distributions using cluster identification, characterization, and regression software. The amenability of the approach to scalability was evaluated in a micro-scale stirred tank bioreactor. Surface concentration of Delta-Like 1 was well controlled used differing stoichiometric reagent ratios. Protein immobilisation was a cost effective process and particles were efficiently removed from the final cell product. Immobilised Delta-Like 1 is functional and stimulates qualitatively similar CD34(hi), CD38(lo), CD90(lo), CD133(hi), CD135(hi) progenitor expansion in both static culture and scalable stirred culture platforms. CONCLUSIONS: Immobilised Delta-Like 1 in this form has the potential to improve the manufacturing efficiency and control of final ex vivo expanded cell product through compatibility with highly controlled and characterised suspension culture systems. 2017-08-04T00:00:00Z Text Journal contribution 2134/26082 https://figshare.com/articles/journal_contribution/Immobilisation_of_Delta-like_1_ligand_for_the_scalable_and_controlled_manufacture_of_hematopoietic_progenitor_cells_in_a_stirred_bioreactor_/9564008 CC BY 4.0
institution Loughborough University
collection Figshare
topic Mechanical engineering not elsewhere classified
Cell culture
Delta-like 1
Ex vivo expansion
Hematopoietic progenitor cell
Immobilised
Manufacturing
Notch
Scalable
Mechanical Engineering not elsewhere classified
spellingShingle Mechanical engineering not elsewhere classified
Cell culture
Delta-like 1
Ex vivo expansion
Hematopoietic progenitor cell
Immobilised
Manufacturing
Notch
Scalable
Mechanical Engineering not elsewhere classified
Rebecca Moore
Matthew J. Worrallo
Peter D. Mitchell
Jon Harriman
Katie Glen
Rob Thomas
Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.
description BACKGROUND: Umbilical cord blood provides a source of hematopoietic stem cells for transplantation with immunological and availability advantages over conventional bone marrow sources. Limited cell numbers and slower engraftment from umbilical cord blood units has led to the clinical development of immobilised Notch ligand Delta-Like 1 to promote ex vivo expansion of a rapidly engrafting cell population. However, current immobilisation methods are not simple to scale in a controlled manner. RESULTS: Delta-Like 1 was immobilised onto streptavidin coated magnetic particles via a heterobifunctionalised polyethylene glycol linker molecule to provide an easily manipulated format of surface protein presentation. CD34(+) enriched cord blood cells were treated with Delta-Like 1 immobilised particles, and immunophenotypic markers measured to monitor population distributions using cluster identification, characterization, and regression software. The amenability of the approach to scalability was evaluated in a micro-scale stirred tank bioreactor. Surface concentration of Delta-Like 1 was well controlled used differing stoichiometric reagent ratios. Protein immobilisation was a cost effective process and particles were efficiently removed from the final cell product. Immobilised Delta-Like 1 is functional and stimulates qualitatively similar CD34(hi), CD38(lo), CD90(lo), CD133(hi), CD135(hi) progenitor expansion in both static culture and scalable stirred culture platforms. CONCLUSIONS: Immobilised Delta-Like 1 in this form has the potential to improve the manufacturing efficiency and control of final ex vivo expanded cell product through compatibility with highly controlled and characterised suspension culture systems.
format Default
Article
author Rebecca Moore
Matthew J. Worrallo
Peter D. Mitchell
Jon Harriman
Katie Glen
Rob Thomas
author_facet Rebecca Moore
Matthew J. Worrallo
Peter D. Mitchell
Jon Harriman
Katie Glen
Rob Thomas
author_sort Rebecca Moore (1253241)
title Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.
title_short Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.
title_full Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.
title_fullStr Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.
title_full_unstemmed Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.
title_sort immobilisation of delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.
publishDate 2017
url https://hdl.handle.net/2134/26082
_version_ 1797555730895601664